PRE-GERMINATION TREATMENT OF CARROT SEEDS WITH BIOACTIVATOR

Carrot is a vegetable with an important socio-economic role, both due to the employment of labor and high commercialization. To optimize the establishment of this crop in fields, seeds with rapid and uniform germination are essential. Therefore, various seed treatment techniques have been used to enable and enhance the germination percentage and optimize the vigor of the seeds. In continuation with this, the objective of this study was to evaluate the effects of thiamethoxam on the physiological performance of carrot seeds during germination and initial development of seedlings. The experimental design was a completely randomized design in a 5 × 4 factorial scheme, with five carrot cultivars and four doses of thiamethoxam (0, 0.4, 0.8, and 1.2 mL). Parameters such as germination, first germination count, seedling length, and dry mass were evaluated. In addition, biochemical analyses of total sugars, total amino acids, and proline content were performed. In general, the treatment of carrot seeds with thiamethoxam positively influenced the germination of the seeds of the cultivars studied. However, thiamethoxam doses of 0.4 and 0.8 mL had no positive effect on the seedling development of the Tropical cultivar. The thiamethoxam dose of 1.2 mL was beneficial to the development of seedlings and accumulation of metabolites in the Alvorada cultivar.A cenoura é uma hortaliça com papel socioeconômico importante, tanto pelo elevado emprego de mão-de-obra, quanto por sua alta comercialização. Para otimizar o estabelecimento dessa cultura em campo se torna imprescindível sementes com germinação rápida e uniforme. Por isso, tem-se utilizado o tratamento de sementes como técnica para viabilizar o desempenho germinativo e expressão de vigor. Desse modo, objetivou-se avaliar os efeitos do tiametoxam no desempenho fisiológico de sementes de cenoura durante a germinação e desenvolvimento inicial de plântulas. O delineamento experimental foi o inteiramente casualizado, em esquema fatorial 5 x 4, sendo cinco cultivares de cenoura e quatro dosagens de tiametoxam (0; 0,4; 0,8 e 1,2 mL). Avaliaram-se a germinação, primeira contagem de germinação, comprimento e massa seca de plântula, além de análises bioquímicas do conteúdo de açúcares totais, aminoácidos totais e prolina. Os dados coletados foram submetidos à análise de variância (p ≤ 0,05) seguido do teste de Tukey e análise de regressão. O tratamento de sementes de cenoura com tiametoxam, no geral, influenciou positivamente a germinação das sementes das cultivares estudadas. No entanto, as dosagens de 0,4 e 0,8 mL de tiametoxam para cultivar Tropical não houve influência positivamente o desenvolvimento de plântulas. A dose de 1,2 mL do bioativador, para a cultivar Alvorada, foi benéfico ao desenvolvimento de plântulas e acúmulo de metabólitos

Pre-germination treatments with plant growth regulators and bioactivators attenuate salt stress in melon: effects on germination and seedling development

The scarcity of surface water has led to the use of underground sources as an alternative for crop irrigation by farmers in semi-arid regions. However, these water sources generally have high salinity, which prevents agricultural production. The objective of this study was to determine the effects of pre-germination treatments with plant growth regulators and bioactivators on melon seeds to attenuate salt stress caused by irrigation water during germination and seedling development. Two trials were carried out separately with the hybrids, Goldex and Grand Prix. The design was completely randomized in a 4 × 3 factorial scheme (four seed treatments and three dilutions of irrigation water). Seeds were treated with salicylic acid and gibberellic acid and the insecticide, thiamethoxam, in addition to the control. Local supply water, artesian well groundwater, and dilution of these waters at a 1:1 ratio were employed for irrigation. Fourteen days after sowing, morphological and physiological analyses were performed, and the material was collected for biochemical determination. The use of saline well water affected the initial development of melon seedlings of the Goldex and Grand Prix hybrids. Pre-germination treatment of Goldex hybrid seeds with gibberellic acid was inefficient at mitigating salt stress. However, the effects of irrigation water salinity on Grand Prix melon seeds pretreated with salicylic acid and thiamethoxam were attenuated

COVID-19 outcomes in people living with HIV: Peering through the waves

Objective: To evaluate clinical characteristics and outcomes of COVID-19 patients infected with HIV, and to compare with a paired sample without HIV infection. Methods: This is a substudy of a Brazilian multicentric cohort that comprised two periods (2020 and 2021). Data was obtained through the retrospective review of medical records. Primary outcomes were admission to the intensive care unit, invasive mechanical ventilation, and death. Patients with HIV and controls were matched for age, sex, number of comorbidities, and hospital of origin using the technique of propensity score matching (up to 4:1). They were compared using the Chi-Square or Fisher's Exact tests for categorical variables and the Wilcoxon for numerical variables. Results: Throughout the study, 17,101 COVID-19 patients were hospitalized, and 130 (0.76%) of those were infected with HIV. The median age was 54 (IQR: 43.0;64.0) years in 2020 and 53 (IQR: 46.0;63.5) years in 2021, with a predominance of females in both periods. People Living with HIV (PLHIV) and their controls showed similar prevalence for admission to the ICU and invasive mechanical ventilation requirement in the two periods, with no significant differences. In 2020, in-hospital mortality was higher in the PLHIV compared to the controls (27.9% vs. 17.7%; p = 0.049), but there was no difference in mortality between groups in 2021 (25.0% vs. 25.1%; p > 0.999). Conclusions: Our results reiterate that PLHIV were at higher risk of COVID-19 mortality in the early stages of the pandemic, however, this finding did not sustain in 2021, when the mortality rate is similar to the control group

Erratum to: The study of cardiovascular risk in adolescents – ERICA: rationale, design and sample characteristics of a national survey examining cardiovascular risk factor profile in Brazilian adolescents

1585

Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear un derstanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5–7 vast areas of the tropics remain understudied.8–11 In the American tropics, Amazonia stands out as the world’s most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepre sented in biodiversity databases.13–15 To worsen this situation, human-induced modifications16,17 may elim inate pieces of the Amazon’s biodiversity puzzle before we can use them to understand how ecological com munities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple or ganism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region’s vulnerability to environmental change. 15%–18% of the most ne glected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lostinfo:eu-repo/semantics/publishedVersio

Diretriz da Sociedade Brasileira de Cardiologia sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas

This guideline aimed to update the concepts and formulate the standards of conduct and scientific evidence that support them, regarding the diagnosis and treatment of the Cardiomyopathy of Chagas disease, with special emphasis on the rationality base that supported it.  Chagas disease in the 21st century maintains an epidemiological pattern of endemicity in 21 Latin American countries. Researchers and managers from endemic and non-endemic countries point to the need to adopt comprehensive public health policies to effectively control the interhuman transmission of T. cruzi infection, and to obtain an optimized level of care for already infected individuals, focusing on diagnostic and therapeutic opportunistic opportunities.   Pathogenic and pathophysiological mechanisms of the Cardiomyopathy of Chagas disease were revisited after in-depth updating and the notion that necrosis and fibrosis are stimulated by tissue parasitic persistence and adverse immune reaction, as fundamental mechanisms, assisted by autonomic and microvascular disorders, was well established. Some of them have recently formed potential targets of therapies.  The natural history of the acute and chronic phases was reviewed, with enhancement for oral transmission, indeterminate form and chronic syndromes. Recent meta-analyses of observational studies have estimated the risk of evolution from acute and indeterminate forms and mortality after chronic cardiomyopathy. Therapeutic approaches applicable to individuals with Indeterminate form of Chagas disease were specifically addressed. All methods to detect structural and/or functional alterations with various cardiac imaging techniques were also reviewed, with recommendations for use in various clinical scenarios. Mortality risk stratification based on the Rassi score, with recent studies of its application, was complemented by methods that detect myocardial fibrosis.  The current methodology for etiological diagnosis and the consequent implications of trypanonomic treatment deserved a comprehensive and in-depth approach. Also the treatment of patients at risk or with heart failure, arrhythmias and thromboembolic events, based on pharmacological and complementary resources, received special attention. Additional chapters supported the conducts applicable to several special contexts, including t. cruzi/HIV co-infection, risk during surgeries, in pregnant women, in the reactivation of infection after heart transplantation, and others.     Finally, two chapters of great social significance, addressing the structuring of specialized services to care for individuals with the Cardiomyopathy of Chagas disease, and reviewing the concepts of severe heart disease and its medical-labor implications completed this guideline.Esta diretriz teve como objetivo principal atualizar os conceitos e formular as normas de conduta e evidências científicas que as suportam, quanto ao diagnóstico e tratamento da CDC, com especial ênfase na base de racionalidade que a embasou. A DC no século XXI mantém padrão epidemiológico de endemicidade em 21 países da América Latina. Investigadores e gestores de países endêmicos e não endêmicos indigitam a necessidade de se adotarem políticas abrangentes, de saúde pública, para controle eficaz da transmissão inter-humanos da infecção pelo T. cruzi, e obter-se nível otimizado de atendimento aos indivíduos já infectados, com foco em oportunização diagnóstica e terapêutica. Mecanismos patogênicos e fisiopatológicos da CDC foram revisitados após atualização aprofundada e ficou bem consolidada a noção de que necrose e fibrose sejam estimuladas pela persistência parasitária tissular e reação imune adversa, como mecanismos fundamentais, coadjuvados por distúrbios autonômicos e microvasculares. Alguns deles recentemente constituíram alvos potenciais de terapêuticas. A história natural das fases aguda e crônica foi revista, com realce para a transmissão oral, a forma indeterminada e as síndromes crônicas. Metanálises recentes de estudos observacionais estimaram o risco de evolução a partir das formas aguda e indeterminada e de mortalidade após instalação da cardiomiopatia crônica. Condutas terapêuticas aplicáveis aos indivíduos com a FIDC foram abordadas especificamente. Todos os métodos para detectar alterações estruturais e/ou funcionais com variadas técnicas de imageamento cardíaco também foram revisados, com recomendações de uso nos vários cenários clínicos. Estratificação de risco de mortalidade fundamentada no escore de Rassi, com estudos recentes de sua aplicação, foi complementada por métodos que detectam fibrose miocárdica. A metodologia atual para diagnóstico etiológico e as consequentes implicações do tratamento tripanossomicida mereceram enfoque abrangente e aprofundado. Também o tratamento de pacientes em risco ou com insuficiência cardíaca, arritmias e eventos tromboembólicos, baseado em recursos farmacológicos e complementares, recebeu especial atenção. Capítulos suplementares subsidiaram as condutas aplicáveis a diversos contextos especiais, entre eles o da co-infecção por T. cruzi/HIV, risco durante cirurgias, em grávidas, na reativação da infecção após transplante cardíacos, e outros.    Por fim, dois capítulos de grande significado social, abordando a estruturação de serviços especializados para atendimento aos indivíduos com a CDC, e revisando os conceitos de cardiopatia grave e suas implicações médico-trabalhistas completaram esta diretriz.&nbsp